These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35530699)

  • 1. AuNP and ssDNA capped mesoporous silica nanoparticles for laser controlled drug release.
    Zhou L; Liu G; Wang Y; Liu J; Zhang Y; Ma Y
    RSC Adv; 2019 Oct; 9(60):34958-34962. PubMed ID: 35530699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gold-capped mesoporous silica nanoparticles as an excellent enzyme-responsive nanocarrier for controlled doxorubicin delivery.
    Eskandari P; Bigdeli B; Porgham Daryasari M; Baharifar H; Bazri B; Shourian M; Amani A; Sadighi A; Goliaei B; Khoobi M; Saboury AA
    J Drug Target; 2019 Dec; 27(10):1084-1093. PubMed ID: 30900473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesoporous silica nanoparticles combining Au particles as glutathione and pH dual-sensitive nanocarriers for doxorubicin.
    Xu S; Li Y; Chen Z; Hou C; Chen T; Xu Z; Zhang X; Zhang H
    Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():258-264. PubMed ID: 26652372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
    Xie Z; Gong H; Liu M; Zhu H; Sun H
    J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesoporous silica nanoparticles capped with disulfide-linked PEG gatekeepers for glutathione-mediated controlled release.
    Cui Y; Dong H; Cai X; Wang D; Li Y
    ACS Appl Mater Interfaces; 2012 Jun; 4(6):3177-83. PubMed ID: 22646097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and characterization of a temperature-responsive nanocarrier for imidacloprid based on mesoporous silica nanoparticles.
    Yao P; Zou A; Tian Z; Meng W; Fang X; Wu T; Cheng J
    Colloids Surf B Biointerfaces; 2021 Feb; 198():111464. PubMed ID: 33296822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multifunctional biphasic suspension of mesoporous silica encapsulated with YVO4:Eu3+ and Fe3O4 nanoparticles: synergistic effect towards cancer therapy and imaging.
    Shanta Singh N; Kulkarni H; Pradhan L; Bahadur D
    Nanotechnology; 2013 Feb; 24(6):065101. PubMed ID: 23324398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance.
    Shao M; Chang C; Liu Z; Chen K; Zhou Y; Zheng G; Huang Z; Xu H; Xu P; Lu B
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110427. PubMed ID: 31408782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodal nanoporous silica nanoparticles functionalized with aminopropyl groups for improving loading and controlled release of doxorubicin hydrochloride.
    Wang X; Li C; Fan N; Li J; He Z; Sun J
    Mater Sci Eng C Mater Biol Appl; 2017 Sep; 78():370-375. PubMed ID: 28575997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan.
    Zhang Y; Zhi Z; Jiang T; Zhang J; Wang Z; Wang S
    J Control Release; 2010 Aug; 145(3):257-63. PubMed ID: 20450945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polydopamine and peptide decorated doxorubicin-loaded mesoporous silica nanoparticles as a targeted drug delivery system for bladder cancer therapy.
    Wei Y; Gao L; Wang L; Shi L; Wei E; Zhou B; Zhou L; Ge B
    Drug Deliv; 2017 Nov; 24(1):681-691. PubMed ID: 28414557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TPGS-Functionalized Polydopamine-Modified Mesoporous Silica as Drug Nanocarriers for Enhanced Lung Cancer Chemotherapy against Multidrug Resistance.
    Cheng W; Liang C; Xu L; Liu G; Gao N; Tao W; Luo L; Zuo Y; Wang X; Zhang X; Zeng X; Mei L
    Small; 2017 Aug; 13(29):. PubMed ID: 28594473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodal Mesoporous Silica Nanocarriers for Dual Stimuli-Responsive Drug Release and Excellent Photothermal Ablation of Cancer Cells.
    Tran VA; Vo VG; Shim K; Lee SW; An SSA
    Int J Nanomedicine; 2020; 15():7667-7685. PubMed ID: 33116494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immobilization of gold nanoparticles on folate-conjugated dendritic mesoporous silica-coated reduced graphene oxide nanosheets: a new nanoplatform for curcumin pH-controlled and targeted delivery.
    Malekmohammadi S; Hadadzadeh H; Farrokhpour H; Amirghofran Z
    Soft Matter; 2018 Mar; 14(12):2400-2410. PubMed ID: 29512668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hollow Mesoporous Silica Nanoparticles Gated by Chitosan-Copper Sulfide Composites as Theranostic Agents for the Treatment of Breast Cancer.
    Niu S; Zhang X; Williams GR; Wu J; Gao F; Fu Z; Chen X; Lu S; Zhu LM
    Acta Biomater; 2021 May; 126():408-420. PubMed ID: 33731303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lectin-conjugated pH-responsive mesoporous silica nanoparticles for targeted bone cancer treatment.
    Martínez-Carmona M; Lozano D; Colilla M; Vallet-Regí M
    Acta Biomater; 2018 Jan; 65():393-404. PubMed ID: 29127069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hierarchical Core-Shell Fe₃O₄@mSiO₂@Chitosan Nanoparticles for pH-Responsive Drug Delivery.
    Zhang N; Jia C; Ma X; Li J; Wang S; Yue B; Huang M
    J Nanosci Nanotechnol; 2021 May; 21(5):3020-3027. PubMed ID: 33653475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.
    Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K
    J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fabrication of Chitosan-coated Mesoporous Silica Nanoparticles Bearing Rosuvastatin as a Drug Delivery System.
    Ghahfarokhi MR; Dini G; Movahedi B
    Curr Drug Deliv; 2022; 19(1):64-73. PubMed ID: 34151762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel functional mesoporous silica nanoparticles loaded with Vitamin E acetate as smart platforms for pH responsive delivery with high bioactivity.
    Mai Z; Chen J; Hu Y; Liu F; Fu B; Zhang H; Dong X; Huang W; Zhou W
    J Colloid Interface Sci; 2017 Dec; 508():184-195. PubMed ID: 28841476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.